credit / rates affecting interest expense
“The decrease was due to lower interest expense from the Blackstone Loan Agreement, which was partially offset by less interest income from lower interest rates.”
AXSM 10-Q
6 names are moving together; 50% are participating in the current session.
Observed intraday paths are not available for this group yet.
| TICKER | Company | Sector | Today | Observed activity |
|---|---|---|---|---|
| HWKN | Hawkins, Inc. | Basic Materials | +3.4% | Group member |
| AXSM | Axsome Therapeutics, Inc. | Healthcare | +3.0% | Most structurally connected |
| EPAC | Enerpac Tool Group Corp. | Industrials | -1.9% | Group member |
| KMT | Kennametal Inc. | Industrials | +2.0% | Group member |
| AIT | Applied Industrial Technologies | Industrials | -0.5% | Group member |
| DFTX | Definium Therapeutics, Inc. | Healthcare | +5.3% | Group member |
Cohort
6 namesParticipation
50% this sessionObserved history
1 daily buildsFiling coverage
6/6 memberscredit / rates affecting interest expense
“The decrease was due to lower interest expense from the Blackstone Loan Agreement, which was partially offset by less interest income from lower interest rates.”
AXSM 10-Q
pricing affecting revenue
“The increase in product organic sales was driven by pricing actions and mix within the IT&S product offerings; however, this was partially offset by a decrease in product organic sales in the Cortland Medical business due to softness in demand related to certain surgical procedures utilizing Cortland Biomedical products.”
EPAC 10-K
restructuring
“If our operations are found to be in violation of any of such health regulatory laws or regulations described above or any other governmental laws or regulations that apply to us, we may be subject to penalties or other enforcement actions, including, without limitation, civil, administrative, and criminal penalties, damages, fines, disgorgement, the curtailment or restructuring of our operations, exclusion from participation in federal and state healthcare programs, individual imprisonment, injunctions, private qui tam actions brought by individual whistleblowers in the name of the government, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, any of which could adversely affect our ability to operate our business and our financial results.”
AXSM 10-K
Industrial Automation & Biotech can stay leader-led if AIT and the next software names fail to join while AXSM keeps moving.
No high-confidence filing-linked non-members are available for this group yet.
Historical cohort observations are not available yet.